HK1187838A1 - 胡桐素及胡桐素衍生物和類似物的藥物組合物及其製備方法 - Google Patents
胡桐素及胡桐素衍生物和類似物的藥物組合物及其製備方法Info
- Publication number
- HK1187838A1 HK1187838A1 HK14101153.5A HK14101153A HK1187838A1 HK 1187838 A1 HK1187838 A1 HK 1187838A1 HK 14101153 A HK14101153 A HK 14101153A HK 1187838 A1 HK1187838 A1 HK 1187838A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- calanolides
- analogues
- derivatives
- producing
- same
- Prior art date
Links
- 229930184135 calanolide Natural products 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- AIDS & HIV (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2010004411A MY158809A (en) | 2010-09-22 | 2010-09-22 | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
PCT/MY2011/000192 WO2012039596A2 (en) | 2010-09-22 | 2011-08-24 | Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1187838A1 true HK1187838A1 (zh) | 2014-04-17 |
Family
ID=45375487
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14101153.5A HK1187838A1 (zh) | 2010-09-22 | 2014-02-07 | 胡桐素及胡桐素衍生物和類似物的藥物組合物及其製備方法 |
Country Status (13)
Country | Link |
---|---|
US (1) | US20130183383A1 (zh) |
EP (1) | EP2618815B1 (zh) |
JP (2) | JP2013537903A (zh) |
KR (1) | KR101710435B1 (zh) |
CN (1) | CN103249403B (zh) |
AU (1) | AU2011306573C1 (zh) |
CA (1) | CA2812372C (zh) |
ES (1) | ES2657813T3 (zh) |
HK (1) | HK1187838A1 (zh) |
MY (1) | MY158809A (zh) |
SG (1) | SG188263A1 (zh) |
WO (1) | WO2012039596A2 (zh) |
ZA (1) | ZA201301463B (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013032934A1 (en) * | 2011-08-26 | 2013-03-07 | Aegis Therapeutics, Llc | Compositions and methods thereof for oral administration of drugs |
WO2014165607A2 (en) * | 2013-04-02 | 2014-10-09 | Stealth Peptides International, Inc. | Aromatic-cationic peptide formulations, compositions and methods of use |
KR102178448B1 (ko) | 2014-04-11 | 2020-11-18 | 주식회사 만도 | 브레이크 시스템용 솔레노이드밸브 |
ES2877107T3 (es) | 2014-08-28 | 2021-11-16 | Univ Texas | Formulaciones de testosterona y procedimientos de tratamiento con ellas |
KR102351762B1 (ko) * | 2016-03-02 | 2022-01-18 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 테스토스테론 제형 및 이를 이용한 치료 방법 |
WO2017149492A1 (en) | 2016-03-02 | 2017-09-08 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
CN105832752A (zh) * | 2016-04-08 | 2016-08-10 | 王金霞 | 一种临床护理上呼吸道感染的药物组合物 |
WO2019191734A1 (en) * | 2018-03-30 | 2019-10-03 | The Board Of Trustees Of The Leland Stanford Junior University | Sublingual and buccal administrations of fluorescent agents for optical imaging |
CA3111901A1 (en) | 2018-09-07 | 2020-03-12 | Prakash SUNDARAMURTHI | Medroxyprogesterone acetate injectable compositions and methods of use |
JP7238130B2 (ja) * | 2018-12-07 | 2023-03-13 | ニューロクライン バイオサイエンシーズ,インコーポレイテッド | 先天性副腎過形成を処置するためのcrf1受容体アンタゴニスト、その医薬製剤および固体形態 |
AU2020346414A1 (en) * | 2019-09-12 | 2022-04-14 | BioVersys AG | Rifabutin treatment methods, uses, and compositions |
US11344537B2 (en) | 2019-09-18 | 2022-05-31 | BioVersys AG | Rifabutin treatment methods, uses, and compositions |
MX2022013090A (es) * | 2020-04-20 | 2022-11-14 | Poviva Corp | Composiciones y metodos para el suministro mejorado de agentes antivirales. |
CN117462551B (zh) * | 2023-12-27 | 2024-05-17 | 深圳国家感染性疾病临床医学研究中心 | 茚地那韦和/或其衍生物在制备抗结核药物中的应用 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5591770A (en) * | 1992-03-31 | 1997-01-07 | The United States Of America As Represented By The Department Of Health And Human Services | Calanolide and related antiretroviral compounds, compositions, and uses thereof |
JP3103114B2 (ja) * | 1992-03-31 | 2000-10-23 | アメリカ合衆国 | カラノライド抗ウイルス性化合物、組成物およびその用途 |
GB9405304D0 (en) * | 1994-03-16 | 1994-04-27 | Scherer Ltd R P | Delivery systems for hydrophobic drugs |
US6268939B1 (en) * | 1998-01-08 | 2001-07-31 | Xerox Corporation | Method and apparatus for correcting luminance and chrominance data in digital color images |
EP1143952B1 (en) * | 1998-10-15 | 2003-02-26 | Sarawak Medichem Pharmaceuticals Inc. | Method and composition for treating and preventing tuberculosis |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
GB9912476D0 (en) * | 1999-05-28 | 1999-07-28 | Novartis Ag | Organic compounds |
JP4298998B2 (ja) * | 2000-10-31 | 2009-07-22 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | ピラノンプロテアーゼインヒビターの経口投与自己乳化製剤 |
FR2861992B1 (fr) * | 2003-11-10 | 2007-07-20 | Sanofi Synthelabo | Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide. |
CA2571726C (en) * | 2004-07-06 | 2013-05-21 | Abbott Laboratories | Prodrugs of hiv protease inhibitors |
CN1853728A (zh) * | 2005-04-19 | 2006-11-01 | 上海天博生物科技有限公司 | 一种改善药物或营养物口服吸收的方法、配方及其应用 |
WO2007016766A1 (en) * | 2005-08-05 | 2007-02-15 | Nuvo Research Inc. | Transdermal drug delivery formulation |
SI2049506T2 (sl) * | 2006-07-07 | 2024-07-31 | Gilead Sciences, Inc. | Modulatorji farmakokinetičnih lastnosti terapevtikov |
KR20090040449A (ko) * | 2006-07-24 | 2009-04-24 | 길리애드 사이언시즈, 인코포레이티드 | 신규 hiv 역전사 효소 억제제 |
US20090130198A1 (en) * | 2007-11-21 | 2009-05-21 | Innopharmax Inc. | Pharmaceutical composition with enhanced bioavailability |
-
2010
- 2010-09-22 MY MYPI2010004411A patent/MY158809A/en unknown
-
2011
- 2011-08-24 AU AU2011306573A patent/AU2011306573C1/en not_active Ceased
- 2011-08-24 WO PCT/MY2011/000192 patent/WO2012039596A2/en active Application Filing
- 2011-08-24 EP EP11770892.5A patent/EP2618815B1/en not_active Not-in-force
- 2011-08-24 KR KR1020137010033A patent/KR101710435B1/ko active IP Right Grant
- 2011-08-24 CN CN201180045624.XA patent/CN103249403B/zh not_active Expired - Fee Related
- 2011-08-24 ES ES11770892.5T patent/ES2657813T3/es active Active
- 2011-08-24 SG SG2013013024A patent/SG188263A1/en unknown
- 2011-08-24 US US13/825,448 patent/US20130183383A1/en not_active Abandoned
- 2011-08-24 JP JP2013530106A patent/JP2013537903A/ja active Pending
- 2011-08-24 CA CA2812372A patent/CA2812372C/en not_active Expired - Fee Related
-
2013
- 2013-02-26 ZA ZA2013/01463A patent/ZA201301463B/en unknown
-
2014
- 2014-02-07 HK HK14101153.5A patent/HK1187838A1/zh not_active IP Right Cessation
-
2015
- 2015-11-02 JP JP2015215932A patent/JP6240646B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2011306573C1 (en) | 2015-02-19 |
EP2618815A2 (en) | 2013-07-31 |
SG188263A1 (en) | 2013-04-30 |
US20130183383A1 (en) | 2013-07-18 |
JP2016053059A (ja) | 2016-04-14 |
WO2012039596A2 (en) | 2012-03-29 |
JP2013537903A (ja) | 2013-10-07 |
KR101710435B1 (ko) | 2017-03-08 |
JP6240646B2 (ja) | 2017-11-29 |
WO2012039596A3 (en) | 2012-08-16 |
ZA201301463B (en) | 2019-07-31 |
AU2011306573B2 (en) | 2014-10-23 |
CN103249403B (zh) | 2016-01-27 |
CN103249403A (zh) | 2013-08-14 |
EP2618815B1 (en) | 2017-11-15 |
ES2657813T3 (es) | 2018-03-07 |
CA2812372C (en) | 2018-08-21 |
CA2812372A1 (en) | 2012-03-29 |
AU2011306573A1 (en) | 2013-04-11 |
KR20140043297A (ko) | 2014-04-09 |
MY158809A (en) | 2016-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL279304A (en) | History of cytotoxic benzodiazepines, preparations containing them and their uses | |
HK1187838A1 (zh) | 胡桐素及胡桐素衍生物和類似物的藥物組合物及其製備方法 | |
IL216826A0 (en) | Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same | |
IL233154A (en) | Compounds, pharmaceuticals containing them and their uses | |
EP2746283A4 (en) | PYRIMIDOPYRIMIDONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES | |
ZA201300100B (en) | Indolizine derivatives,process for the preparation thereof and therapeutic use thereof | |
IL232914A0 (en) | New Azetidine histories, pharmaceutical preparations and their uses | |
HUE037747T2 (hu) | Nanostrukturált aprepirant készítmények, eljárások azok elõállítására és az azokat tartalmazó gyógyászati készítmények | |
EP2562172A4 (en) | SPHAELACTON DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION AND THEIR USE | |
IL232577A (en) | History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations | |
IL212942A (en) | History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses | |
EP2742020A4 (en) | N1-CYCLIC AMIN-N5-SUBSTITUTED BIGUANIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH | |
EP2386553A4 (en) | BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES, METHODS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
IL228705A (en) | Derivatives of Reliable Phenoxy-Ethyl, Pharmaceutical Preparations Containing and Using Them | |
IL230219A0 (en) | History of dihydropyrazole, their preparation and pharmaceutical preparations containing them | |
EP2742946A4 (en) | PROCESS FOR THE PRODUCTION OF PYROSTEGIA VENUSTA DERIVATIVES, PYROSTEGIA VENUSTA DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | |
ZA201209674B (en) | Pharmaceutical compositions comprising paracetamol and process for preparing the same | |
IL222351A (en) | Process for making derivatives 4,1-diethylene-di (3-pyroline) -tetrone | |
IL225823A0 (en) | History of quinazoline, their preparation and pharmaceutical preparations containing them | |
EP2704570A4 (en) | ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
EP2222624A4 (en) | 4-NEROLIDYLCATECHOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THESE DERIVATIVES AND PREPARATION METHOD THEREOF | |
IL227688A0 (en) | History of aminostatin, their preparation and pharmaceutical preparations containing them | |
IL225378A0 (en) | History of phenylquinazoline, their preparation and pharmaceutical preparations containing them | |
SI2497774T1 (sl) | Derivati dihidrooksazolobenzodiazepinona, postopki za njihovo pripravo in farmacevtski sestavki, ki te spojine vsebujejo | |
PL393254A1 (pl) | Nowe pochodne betuliny i sposób ich otrzymywania |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200828 |